Bioarray Genetics, Inc. — Form D
Bioarray Genetics, Inc. of Farmington, CT, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-26. The offering totals $5.2M, of which $5.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-09-26
- Form: D
- Accession: 0001641015-17-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.2M
- Amount sold: $5.2M
- Investors: 20
- Date of first sale: 2017-09-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-295381
Issuer
- Name: Bioarray Genetics, Inc.
- CIK: 0001641015
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 400 Farmington Avenue, Farmington, CT, 06032
- Phone: (508) 577-0205
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Zafrira Avnur | Director | Framingham, MA |
| Marcia Fournier | Director | Farmington, CT |
| Henry Kay | Director | Farmington, CT |
| Jim LaFrance | Director | Farmington, CT |
| Pamela Layton | Director | Farmington, CT |
| Pauline Murphy | Director | Norwalk, CT |
| Michal Preminger | Director | Farmington, CT |
| Marcia Fournier | Executive Officer | Farmington, CT |
| Pamela Layton | Executive Officer | Farmington, CT |
| Una Ryan | Director | South San Francisco, CA |
| Patrick O'Neill | Director | West Hartford, CT |
| Michael Preminger | Director | New Haven, CT |
Other filings by this issuer (1)
More